Dr Kevin T Bauerle, MD | |
1 Barnes Jewish Hospital Plz, Div Im Endocrinology, Saint Louis, MO 63110-1003 | |
(314) 362-3500 | |
(314) 230-1119 |
Full Name | Dr Kevin T Bauerle |
---|---|
Gender | Male |
Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
Location | 1 Barnes Jewish Hospital Plz, Saint Louis, Missouri |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1861757346 | NPI | - | NPPES |
200056702 | Medicaid | MO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 2018006614 (Missouri) | Primary |
207R00000X | Internal Medicine | 2018006614 (Missouri) | Secondary |
Entity Name | Washington University |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1992746903 PECOS PAC ID: 9830008770 Enrollment ID: O20031119000372 |
News Archive
Researchers at Children's Hospital of Philadelphia have demonstrated that an experimental device can improve blood sugar control in patients who developed diabetes after their pancreas was removed to treat their hyperinsulinism, a genetic disease in which the pancreas produces too much insulin.
The Commonwealth of Virginia will receive 60,000 nasopharyngeal swabs weekly to support high-priority COVID-19 testing across the state, thanks to a collaboration led by University of Virginia faculty to design this key testing supply.
"The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria approved an action plan Monday in response to recommendations made recently by the High-Level Independent Review Panel on Fiduciary Controls and Oversight Mechanism (HLP)," the Center for Global Health Policy's "Science Speaks" blog reports, adding, "The board stated that it accepts the underlying analysis made by the panel and that it 'presents a compelling case for a rapid and urgent transformation of the Global Fund.'"
The New York Times looks at the problems that come when the health care program for low-income people doesn't meet their dental needs. At the same time, Minnesota news outlets report on an effort by the governor to get federal authorities to approve changes in the Medicaid program there.
AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today reported unaudited consolidated financial results for the fourth quarter and year ended December 31, 2009.
› Verified 2 days ago
Entity Name | Mercy Hospitals East Communities |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1851431738 PECOS PAC ID: 1658276811 Enrollment ID: O20031218000107 |
News Archive
Researchers at Children's Hospital of Philadelphia have demonstrated that an experimental device can improve blood sugar control in patients who developed diabetes after their pancreas was removed to treat their hyperinsulinism, a genetic disease in which the pancreas produces too much insulin.
The Commonwealth of Virginia will receive 60,000 nasopharyngeal swabs weekly to support high-priority COVID-19 testing across the state, thanks to a collaboration led by University of Virginia faculty to design this key testing supply.
"The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria approved an action plan Monday in response to recommendations made recently by the High-Level Independent Review Panel on Fiduciary Controls and Oversight Mechanism (HLP)," the Center for Global Health Policy's "Science Speaks" blog reports, adding, "The board stated that it accepts the underlying analysis made by the panel and that it 'presents a compelling case for a rapid and urgent transformation of the Global Fund.'"
The New York Times looks at the problems that come when the health care program for low-income people doesn't meet their dental needs. At the same time, Minnesota news outlets report on an effort by the governor to get federal authorities to approve changes in the Medicaid program there.
AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today reported unaudited consolidated financial results for the fourth quarter and year ended December 31, 2009.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Kevin T Bauerle, MD Po Box 60352, Saint Louis, MO 63160-0352 Ph: (314) 362-3500 | Dr Kevin T Bauerle, MD 1 Barnes Jewish Hospital Plz, Div Im Endocrinology, Saint Louis, MO 63110-1003 Ph: (314) 362-3500 |
News Archive
Researchers at Children's Hospital of Philadelphia have demonstrated that an experimental device can improve blood sugar control in patients who developed diabetes after their pancreas was removed to treat their hyperinsulinism, a genetic disease in which the pancreas produces too much insulin.
The Commonwealth of Virginia will receive 60,000 nasopharyngeal swabs weekly to support high-priority COVID-19 testing across the state, thanks to a collaboration led by University of Virginia faculty to design this key testing supply.
"The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria approved an action plan Monday in response to recommendations made recently by the High-Level Independent Review Panel on Fiduciary Controls and Oversight Mechanism (HLP)," the Center for Global Health Policy's "Science Speaks" blog reports, adding, "The board stated that it accepts the underlying analysis made by the panel and that it 'presents a compelling case for a rapid and urgent transformation of the Global Fund.'"
The New York Times looks at the problems that come when the health care program for low-income people doesn't meet their dental needs. At the same time, Minnesota news outlets report on an effort by the governor to get federal authorities to approve changes in the Medicaid program there.
AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today reported unaudited consolidated financial results for the fourth quarter and year ended December 31, 2009.
› Verified 2 days ago
Dr. Isik Turker, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 4921 Parkview Pl, Div Im Cardiology, Ste 8b, Saint Louis, MO 63110 Phone: 314-362-1291 Fax: 314-362-4278 | |
Conor Mccartney, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 915 N Grand Blvd, Saint Louis, MO 63106 Phone: 314-652-4100 | |
Dr. Faris Adam Bakeer, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1 Barnes Jewish Hospital Plz, Div Im Hospitalist, Saint Louis, MO 63110 Phone: 314-362-1700 Fax: 314-362-9878 | |
Rehan Rais, M.D. M.B.,B.S. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 660 S Euclid Ave, Saint Louis, MO 63110 Phone: 314-362-5000 | |
Nathan Farkas, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1 Barnes Jew Hosp Plz, Saint Louis, MO 63110 Phone: 314-362-1930 | |
Dr. Nicole Foley, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110 Phone: 314-362-5000 | |
Soumojit Ghosh, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3660 Vista Ave, Saint Louis, MO 63110 Phone: 314-977-6100 Fax: 314-977-6164 |